# LLM call: summary

- Turn: 8
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 844
- Completion tokens: 352
- Total tokens: 1309
- Cost (USD): 0.000156

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1841: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn-June compute-sovereignty split tied EU money and sensor cover to EU-soil auditable compute. October US model cutoff forced phone/paper and postponed AI radiology; Commission held template, ENISA/health re-routed to EU-hosted open models and pooled inference.

Winter saw machine-assisted modified pathogen release sickening hundreds across two regions; emergency procurement and sealed wards contained it after weeks. Model generation leap made December benchmarks obsolete by March — agentic systems, bottleneck power/chips. US access stayed dark; pooled EU inference kept systems running but radiology backlogs grew. Brussels pushed existing rotations plus limited pilot of automated patching/swarm-detection toolkit, needing more turns.

By June fever curves bent down; soil-anchored compute advanced incrementally.

Autumn 2029 broke rhythm: two tailored therapies — rare immune disorder and winter-pathogen aftermath — reached pharmacies in hardest-hit regions via interpretability certification allowing regulators to approve models, sequencing-to-prescription on pooled EU inference audited on EU soil. Pilot wards in Lyon, Brno, Porto saw recoveries; clinicians cautiously adopted certified summaries with human sign-off. Continuity stack held power/water/records through northern storm; bio-containment patch network blunted intrusions quietly. First gigafactory shells permitted, grid-connected, early racks humming but no frontier training yet. US-China thin accord on securing weights/restricting bio-design tools with spot checks; Brussels excluded, EEAS gained briefings and incident-data invitation only. Municipal data-centre bans in two regions slowed inference; certification questioned as rushed; US frontier dark; radiology backlogs inched down. Survival gave way to proof of domestic delivery.

CURRENT NARRATIVE:
### When the reasoning went dark
The first half of 2030 broke the fragile confidence built around certified cures. Leading labs announced, as a performance gain, that their newest systems no longer reasoned in readable words. Chain-of-thought traces turned to compressed vectors. Overnight, the interpretability certification that had let Lyon, Brno and Porto prescribe sequencing-based therapies lost its object: regulators could no longer show what they had signed off.

Brussels moved fast on paper. The AI Office, ENISA, health emergency bodies and the Joint Research Centre were ordered to build a domestic black-box and activation-inspection lab on pooled inference and spare gigafactory racks, with mandatory re-certification for any model update to health, energy and continuity systems plus screening of biological designs. Reprogramming of existing research budgets avoided a budget fight, but hiring inspectors who could do activation work proved slow, and vendors shared little.

At almost the same moment a contested genome-model paper claimed a non-expert could reach a human-infecting design with assistance. Methodologists quarrelled, but hospital biosafety officers took it seriously. Sealed-ward routines from the winter returned in drills, and the new lab gained urgency it could not yet meet.

### Robots from elsewhere
Commercial humanoids arrived in logistics yards, first for carrying and sorting, then in mine-clearance and armed trials abroad. Europe's machine-tool heartland felt the shock directly: the machines were largely Chinese-built, the control software American, neither available for inspection. A defensive procurement rule quarantining unscreened stacks from critical sites slowed several port and factory pilots and angered mayors promised automation relief.

Cures deployment continued — pharmacies dispensed, backlogs eased slightly — but clinicians, asked to validate outputs no one could read, quietly reverted to manual review in several radiology departments. Grid-connection bans held, and rumours of a wider refusal to sign off machine summaries spread through staff rooms. The concrete was real, but the assurance beneath it had thinned.
```

## Raw response

```
Autumn-June compute-sovereignty split tied EU money to EU-soil auditable compute; October US cutoff forced phone/paper and postponed AI radiology, EU pooled open-model inference kept systems running.

Winter modified-pathogen release sickened hundreds across two regions, contained after weeks. Model leap obsoleted December benchmarks by March; US stayed dark; radiology backlogs grew. Brussels piloted automated patching/swarm-detection.

By June 2029 fever curves bent down. Autumn 2029: two tailored therapies reached pharmacies via interpretability certification, sequencing-to-prescription on pooled EU inference; Lyon, Brno, Porto recoveries; continuity held through storm; gigafactory shells permitted; US-China thin weights/bio accord excluded Brussels; municipal bans slowed inference.

Early 2030: labs shifted to unreadable compressed-vector reasoning, voiding interpretability certification for cures and approvals. Brussels ordered domestic black-box/activation-inspection lab on pooled inference/gigafactory racks with mandatory re-certification and bio-design screening, but hiring and vendor opacity lagged. Contested genome-model paper claiming non-expert human-infecting design revived sealed-ward drills. Chinese-built/American-software humanoids arrived in logistics, then mine-clearance/armed trials; quarantine from critical sites slowed pilots. Cures dispensed but clinicians reverted to manual review in radiology amid refusal to sign off unreadable summaries.
```
